Compounds > celecoxib
Page last updated: 2024-10-24

celecoxib and Angiosarcoma

celecoxib has been researched along with Angiosarcoma in 1 studies

Research Excerpts

ExcerptRelevanceReference
" The aim of this study was to investigate the effects of the COX2 inhibitor celecoxib and the mTOR antagonist rapamycin on angiosarcoma cell lines."7.76Antiproliferative effects of rapamycin and celecoxib in angiosarcoma cell lines. ( Bundscherer, A; Hafner, C; Köhl, G; Landthaler, M; Vogt, T, 2010)
" The aim of this study was to investigate the effects of the COX2 inhibitor celecoxib and the mTOR antagonist rapamycin on angiosarcoma cell lines."3.76Antiproliferative effects of rapamycin and celecoxib in angiosarcoma cell lines. ( Bundscherer, A; Hafner, C; Köhl, G; Landthaler, M; Vogt, T, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bundscherer, A1
Vogt, T1
Köhl, G1
Landthaler, M1
Hafner, C1

Other Studies

1 other study available for celecoxib and Angiosarcoma

ArticleYear
Antiproliferative effects of rapamycin and celecoxib in angiosarcoma cell lines.
    Anticancer research, 2010, Volume: 30, Issue:10

    Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Cel

2010